Entera Non Currrent Assets Other from 2010 to 2025
| ENTX Stock | USD 1.75 0.05 2.78% |
Non Currrent Assets Other | First Reported 2018-09-30 | Previous Quarter 6 K | Current Value 6 K | Quarterly Volatility 304.5 K |
Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 417, Dividend Yield of 0.0 or PTB Ratio of 10.37. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
Entera | Non Currrent Assets Other |
Latest Entera Bio's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Entera Bio over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Entera Bio's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
Entera Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | 59,971 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 664.80 | |
| Mean Deviation | 215,515 | |
| Median | 5,130 | |
| Standard Deviation | 398,683 | |
| Sample Variance | 158.9B | |
| Range | 1.9M | |
| R-Value | (0) | |
| Mean Square Error | 170.3B | |
| R-Squared | 0.000017 | |
| Significance | 0.99 | |
| Slope | (340.96) | |
| Total Sum of Squares | 2.4T |
Entera Non Currrent Assets Other History
About Entera Bio Financial Statements
Entera Bio investors use historical fundamental indicators, such as Entera Bio's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 5.4 K | 5.1 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.